Basic Information
OncoQuest Pharmaceuticals Inc. is a South Korean biopharmaceutical company focused on the development and commercialization of cancer immunotherapies. OncoQuest Pharmaceuticals' technology platform includes a series of tumor antigen-specific monoclonal immunoglobulins targeting CA-125, MUC1, PSA, and Her2/neu.
OncoQuest Pharmaceuticals Inc.
SouthKorea
unclear
--
--
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios